Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My thoughts;
Gale; I am cautious about what to do, they cost me money. I got in deeper than warranted and paid a price for my exuberance.
They have a product but have not shared sales data yet.
Their Phase III is on a vaccine that essentially fails if 1 person gets a recurrence of cancer. If it meets it endpoint then it passes. The difference with CYTR is if everyone does not get cured CYTR's PIII still can pass.
I am concerned that they may have done some illegal activities with the DreamTeam and the new stock issued.
I am waiting to see a new entry point well below today's $3.00
CYTR; got reset to a more realistic $4.00 price.
They have product, Phase III, testing and a good future that will reward investors.
They are accused of a stupid thing, hiring Dream Team and requiring edit rights. This is an open issue for me. They must answer this issue.
I am out now, having booked myself a nice profit and will look for an entry point in the future.
My thoughts;
CYTR; got reset to a more realistic $4.00 price.
They have product, Phase III, testing and a good future that will reward investors.
They are accused of a stupid thing, hiring Dream Team and requiring edit rights. This is an open issue for me. They must answer this issue.
I am out now, having booked myself a nice profit and will look for an entry point in the future.
Gale; I am more cautious about what to do, they cost me money. I got in deeper than warranted and paid a price for my exuberance.
They have a product but have not shared sales data yet.
Their Phase III is on a vaccine that essentially fails if 1 person gets a recurrence of cancer. If it meets it endpoint then it passes. The difference with CYTR is if everyone does not get cured CYTR's PIII still can pass.
I am concerned that they may have done some illegal activities with the DreamTeam and the new stock issued.
I am waiting to see a new entry point well below today's $3.00
Read it Thursday, Now what do you foresee?
My thoughts;
CYTR; got reset to a more realistic $4.00 price.
They have product, Phase III, testing and a good future that will reward investors.
They are accused of a stupid thing, hiring Dream Team and requiring edit rights. This is an open issue for me. They must answer this issue.
I am out now, having booked myself a nice profit and will look for an entry point in the future.
Gale; I am more cautious about what to do, they cost me money. I got in deeper than warranted and paid a price for my exuberance.
They have a product but have not shared sales data yet.
Their Phase III is on a vaccine that essentially fails if 1 person gets a recurrence of cancer. If it meets it endpoint then it passes. The difference with CYTR is if everyone does not get cured CYTR's PIII still can pass.
I am concerned that they may have done some illegal activities with the DreamTeam and the new stock issued.
I am waiting to see a new entry point well below today's $3.00
When is the next Key Event?
We need some constant PR to keep this stock moving in the right direction.
Have you noticed the lack of SEC Investigations?
When the wolves were at the door for LINN Energy last year, the SEC was involved with an investigation. So far only the lawyers are making noise.
BTW, the Linn thing blew over and I think the law firms were left holding their bags.
When is Abstral pain killer sales data due?
That shows a positive bias and the PPS make an upward move.
Since the lawyers think the mgmt team is trying to focus the news perhaps this is a good time to FOCUS.
Found it, thanks
A.F. wrote an article on Street.com
Somebody sell to me @ $3.25
Last Year they were suing Linn Energy
Now they, ambulance chasers, are going after GALE.
Most of these suits don't seem to go anywhere.
I wonder if some of them are just short sponsored law firms.
U R Right about
The criteria the monitors use.
Pump on........ I am wondering about selling now and re-buy on the pull back.
54 institutions, 10.3mil shares
That is a nice cushion against shorts.
Float is 33 mil, and shorts 6.3 mil.
Squeeze could be fun.
I Still think the H.F.II Adage was Best
"Never Explain, Never Complain."
Ahn should have just kept mum, since now there are just more questions.
Yes, Market is closed, Go to the Beach
Read a book or shovel snow.
Speaking of Good Articles on GALE;
http://wallstcheatsheet.com/business/stock-news/ignore-the-drama-heres-why-galena-is-a-good-buy.html/?ref=YF
Hold if you got it, BUY IF YOU CAN............
Class Action; Longs vs Adam Feuerstein & Street?
Where are the lawyers when you need them?
There is a point when journalistic freedom crosses the line. I think he has crossed it and The Street let him do it. They should be put on notice.
OOPS, Sorry
You over estimate the value proposition for lawyers.
They smell Blood..
HE, Cramer, Barrons and SA are too Busy w/ GALE
That is the good news for us MNKD longs.
Sucks to have Gale today, I think they just spread the Pain.
So they Pumped the Stock, Is anything Illegal?
I know we will see a bunch of ambulance chasers with class action suits soon. Just like I saw with Linn energy. They are all gone now, I think. But after the smoke clears what are we looking at?
I am burned at a $3.50 avg but what is a true analysis look like? Someone on SA touted a $1.80 price, he also should be scrutinized for the other direction.
I got that far away look in my eye when I saw it fall to 3.25.
Let's talk.
When will PPHM announce something?
I'm looking for real information. Lots of guessing but nothing from the company.
Market makers or specialists set prices if there is an imbalance of buys or sells.
Where are you getting your data sying more sells than buys?
'In the United States, the New York Stock Exchange (NYSE) and American Stock Exchange (AMEX), among others, have Designated Market Makers, formerly known as "specialists", who act as the official market maker for a given security. The market makers provide a required amount of liquidity to the security's market, and take the other side of trades when there are short-term buy-and-sell-side imbalances in customer orders. In return, the specialist is granted various informational and trade execution advantages.
Other U.S. exchanges, most prominently the NASDAQ Stock Exchange, employ several competing official market makers in a security. These market makers are required to maintain two-sided markets during exchange hours and are obligated to buy and sell at their displayed bids and offers. They typically do not receive the trading advantages a specialist does, but they do get some, such as the ability to naked short a stock, i.e., selling it without borrowing it. In most situations, only official market makers are permitted to engage in naked shorting. Recent changes to the rules have explicitly banned naked shorting by options market makers.'
If someone sells then someone else is buying. How do you see only sellers? The buyers are buying low, to eventually sell .................
Supply and Demand
Until there are no more people willing to sell at 1.18 then we will go to the next group......
Supply and Demand
Until there are no more people willing to sell at 1.18 then we will go to the next group......
8K
http://www.sec.gov/Archives/edgar/data/799698/000119312514029020/d660141ds3mef.htm
Not a lot of shares being offered. Price should recover to $8 today.
IMO Is nothing but a cop out, IMO
Thank You For Your Recommendation
Dumb. A$$
PR About What?
Listing Requirements for NYSE AMEX Stock
Under a buck for 30 days is the first criteria, ergo my concern if mgmt can't feel they can hold the price up, they might do something.
Under a buck starts a review process by the NYSE;
Price Criteria
Average closing price of a security is less than $1.00 over a consecutive 30 trading-day period.
Numerical Criteria for Capital and Common Stock
For companies that listed under the Earnings standard
and Assets & Equity standard
Average global market capitalization over a
consecutive 30 trading-day period is less than $50 million
AND
Total stockholders equity is less than $50 million
OR
Average global market capitalization over a
consecutive 30 trading-day period is less than $15 million
For companies that listed under the Pure Valuation
with Cash Flow standard
Average global market capitalization over a
consecutive 30 trading-day period is less than $250 million
AND
Total revenues for the most recent 12 months $20 million
OR
Average global market capitalization over a
consecutive 30 trading-day period is less than $75 million
I agree
Now take your meds and get some rest.
I don't want it, I am just waiting for it.
If they don't get the PPS over a buck we will probably get one.
RNN is listed on NYSE AMEX. There was a requirement that a stock had to be above $1.00 or be subject to being delisted and sent to 'pink sheets" I don't know what the requirement is now, but in the past if a co was in delisting purgatory they would declare a reverse split to jack up the price of the stock. so 1 for 5 and the stock is now $4.95instead of $0.99.
Just gets more room to fall.
When do we see the reverse split?
History says they will make an announcement if they cannot get over a buck for the required time. Not sure how many days in a row are required.
It's a short attack on Biotech
Just grab what ever makes you feel secure and ride it out........
Now it is a Buy List
Use this correction/pullback as a Buying opportunity